9,10-dimethyl-1,2-benzanthracene has been researched along with mevalonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiki, H; Komori, A; Okabe, S; Suganuma, M; Tius, MA; Zou, X | 1 |
| Andalib, S; Asadpoor, M; Doustar, Y; Garjani, A; Garjani, M; Khorrami, A; Maleki-Dizaji, N; Rezazadeh, H; Soraya, H; Ziaee, M | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and mevalonic acid
| Article | Year |
|---|---|
Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor alpha release and of protein isoprenylation.
Topics: 3T3 Cells; 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Cyclohexanols; Diterpenes; Ethers, Cyclic; Female; Mevalonic Acid; Mice; Okadaic Acid; Protein Prenylation; Skin Neoplasms; Tumor Necrosis Factor-alpha | 1993 |
Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Atorvastatin; Cell Proliferation; Croton Oil; Epidermal Cells; Epidermis; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Skin Neoplasms | 2012 |